WuXi Biologics in Louth receives operational excellence award
The award recognises the company's leadership
WuXi Biologics in Dundalk has announced that its Ireland site has been honored with the prestigious 2025 Operational Excellence in Life Sciences Award at the Ireland Operational Excellence Awards.
While specifically commending the transformative work taking place at the company's Dundalk campus, the award also recognises the company's leadership in process optimization and innovation.
Dr. Chris Chen, CEO of WuXi Biologics, commented: "We are deeply honored to receive this award. WuXi Biologics Ireland exemplifies our CRDMO+ strategy: enabling client success, elevating our global network, empowering innovation, and energizing agile operations.
"With its foundation of operational excellence and sustainability, the Ireland site stands as a commercial manufacturing hub that reflects Ireland's industrial strengths for global partners, and also serves as a blueprint for the future of biologics manufacturing worldwide."
In addition to the Operational Excellence Award, the WuXi Biologics Ireland site has earned several other prestigious honors, including the 2023 ISPE Facility of the Year Award (FOYA), FDI's Grand Prix for "Best Regional Investment" and "Overall Business of the Year" at the 2024 Louth Business Awards.